ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,027.82
      0.55%
      US Tech 100
      20,950.40
      1.09%
      Dow Jones
      44,483.27
      0.14%
      Brent Oil
      76.285
      1.23%
      Bitcoin
      99,518.01
      -1.88%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Genaissance Pharmaceuticals (MM) (GNSC) Quote

      Genaissance Pharmaceuticals (MM)

      Genaissance Pharmaceuticals (MM) (GNSC)

      NASDAQ
      0.00
      0.00
      ( 0.00% )
      Updated: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      -
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      -
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      GNSC Latest News

      More News

      Genaissance Enters into HAP(TM) Technology License Agreement with Sankyo

      NEW HAVEN, Conn. and TOKYO, Oct. 3 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered into an agreement with Sankyo, Co., Ltd...

      October 03 2005
      PR Newswire (US)

      Genaissance Enters Pharmacogenomic Collaboration with Otsuka

      NEW HAVEN, Conn. and TOKYO, Sept. 21 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered into a pharmacogenomic research collaboration...

      September 21 2005
      PR Newswire (US)

      Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research Agreements

      NEW HAVEN, Conn., and MARSEILLE, France, Sept. 12 /PRNewswire-FirstCall/ -- Privately-held Ipsogen SAS and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced today that they have signed...

      September 12 2005
      PR Newswire (US)

      Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract

      - Increases Presence in EU Ag Genotyping Market - NEW HAVEN, Conn., Aug. 23 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced today that it will provide its...

      August 23 2005
      PR Newswire (US)

      Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie Contract

      - Will Address EU Mandate for Sheep-Breeding Programs That Confer Resistance to Scrapie - NEW HAVEN, Conn., Aug. 11 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC...

      August 11 2005
      PR Newswire (US)

      Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon

      Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon NEW HAVEN, Conn. and OSS, Netherlands, July 18 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals...

      July 18 2005
      PR Newswire (US)

      Clinical Data to Acquire Genaissance Pharmaceuticals

      Clinical Data to Acquire Genaissance Pharmaceuticals Combined Company to Deliver Industry-Defining Theranostics NEWTON, Mass., and NEW HAVEN, Conn., June 21 /PRNewswire-FirstCall/ -- Clinical...

      June 21 2005
      PR Newswire (US)

      Clinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining Theranostics

      Clinical Data, Inc. (NASDAQ:CLDA) and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that they have signed an agreement for Clinical Data to acquire Genaissance Pharmaceuticals in...

      June 21 2005
      Business Wire

      Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner

      Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner NEW HAVEN, Conn., June 7 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced...

      June 07 2005
      PR Newswire (US)

      Genaissance Reports First Quarter 2005 Results

      Genaissance Reports First Quarter 2005 Results Company Cites Progress In Key Areas, Including Recent Increase In Cash Reserves NEW HAVEN, Conn., May 3 /PRNewswire-FirstCall/ -- Genaissance...

      May 03 2005
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      GNSC - Frequently Asked Questions (FAQ)

      What is the current Genaissance share price?
      The current share price of Genaissance is $ 0.00
      What is the 1 year trading range for Genaissance share price?
      Genaissance has traded in the range of $ 0.00 to $ 0.00 during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CAPTCaptiVision Inc
      $ 1.13
      (157.40%)
      		211.34M
      QNTMQuantum Biopharma Ltd
      $ 5.51
      (73.27%)
      		46.77M
      LTRYLottery com Inc
      $ 0.5092
      (63.21%)
      		98.68M
      LXEHLixiang Education Holding Company Ltd
      $ 8.2848
      (53.42%)
      		497.49k
      PTIRGraniteShares 2X Long PLTR Daily ETF
      $ 224.87
      (44.78%)
      		1.37M
      OMGAOmega Therapeutics Inc
      $ 0.1516
      (-68.36%)
      		6.39M
      VIRXViracta Therapeutics Inc
      $ 0.0431
      (-44.60%)
      		5.2M
      UPCUniverse Pharmaceuticals Inc
      $ 0.275
      (-34.12%)
      		1.53M
      CYNCYNGN Inc
      $ 0.0816
      (-30.20%)
      		73.88M
      CSAICloudastructure Inc
      $ 13.4999
      (-28.95%)
      		36.5k
      CAPTCaptiVision Inc
      $ 1.13
      (157.40%)
      		211.36M
      PLTRPalantir Technologies Inc
      $ 102.81
      (22.77%)
      		182.79M
      NVDANVIDIA Corporation
      $ 119.345
      (2.30%)
      		166.51M
      RGTIRigetti Computing Inc
      $ 13.7249
      (1.89%)
      		132.68M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.1552
      (-20.37%)
      		102.97M

      GNSC Discussion

      View Posts
      DougS. DougS. 20 years ago
      Thanks. I don't own any. Just curious about the company. I've been waiting for them to take the next step to legitimize their science but it hasn't been forthcoming. Still waiting.

      FYI - a prospectus came out that shows deteriorating financials. So be careful! Good luck.

      http://www.shareholder.com/GNSC/EdgarDetail.cfm?CompanyID=GNSC&CIK=1110009&FID=1047469-05-15...
      👍️0
      gator16 gator16 20 years ago
      I own a lot of GNSC..maybe too much..I keep hearing great things are coming though....guess I will have to wait a while !
      98000 shrs at $3.26 groan !!
      👍️0
      DougS. DougS. 20 years ago
      Anyone out there follow this company besides me???

      👍️0
      gator16 gator16 20 years ago
      Welcome everyone to this new board. This company is the future !!
      👍️0

      Your Recent History

      NASDAQ
      GNSC
      Genaissance
      BIT
      F35805
      Vontobel Financial Produ...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads